-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TgTCPPKUahuhah6M4yqNsKRWuf+l6+GBlQ1A3iH33ZYN7SVYDA7yx5AHoKkvhu+I 0WgmLualfS6aRnES9kIy0g== 0000727008-04-000078.txt : 20041102 0000727008-04-000078.hdr.sgml : 20041102 20041102154204 ACCESSION NUMBER: 0000727008-04-000078 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041030 FILED AS OF DATE: 20041102 DATE AS OF CHANGE: 20041102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EZ EM INC CENTRAL INDEX KEY: 0000727008 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 111999504 STATE OF INCORPORATION: DE FISCAL YEAR END: 0529 BUSINESS ADDRESS: STREET 1: 717 MAIN ST CITY: WESTBURY STATE: NY ZIP: 11590 BUSINESS PHONE: 5163338230 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CURTIN DENNIS J CENTRAL INDEX KEY: 0001235667 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 333-100878 FILM NUMBER: 041113308 BUSINESS ADDRESS: STREET 1: C/O E-Z EM INC STREET 2: 1111 MARCUS AVE CITY: LAKE SUCCESS STATE: NY ZIP: 11042 BUSINESS PHONE: 9149495959 MAIL ADDRESS: STREET 1: 5 GEORGE PL. CITY: WHITE PLAINS STATE: NY ZIP: 10605 4 1 cur117.xml X0202 4 2004-10-30 0 0000727008 EZ EM INC EZM 0001235667 CURTIN DENNIS J 1111 MARCUS AVENUE SUITE LL-26 LAKE SUCCESS NY 110421034 0 1 0 0 Senior Vice President - CFO Common Stock 12891 D Common Stock 507 I As Trustee for Benefit of Children Common Stock Option 2.3681 1996-05-15 2005-05-14 Common Stock 9973 9973 D Denies Beneficial Ownership. Options granted under E-Z-EM's Employee Stock Option Plan. This option was previously reported as covering 10,927 shares at an exercise price of $3.6606 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $2.3681 per share and the number of shares was reduced to 9,973, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. By: Joseph A. Cacchioli, as Attorney-In-Fact 2004-11-02 -----END PRIVACY-ENHANCED MESSAGE-----